FDA Inspection 1187248 — AvKARE

AvKARE — FEI 3007255004

The FDA completed an inspection of AvKARE on Nov 2, 2022 in Pulaski, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 2, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pulaski, TN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.